Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00393107
What this trial is testing

Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab

Who this might be right for
Follicular Lymphoma
Gruppo Italiano Studio Linfomi 54
Testing effectiveness (Phase 2)Study completedNCT01737177
What this trial is testing

Bendamustine/Lenalidomide/Rituximab: Combination as a Second-Line Therapy for 1st Relapsed-Refractory MCL

Who this might be right for
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETS 42
Not applicableUnknownNCT05381077
What this trial is testing

Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner

Who this might be right for
Multiple MyelomaBone Metastases
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 30
Early research (Phase 1)Study completedNCT00850057
What this trial is testing

Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
University of California, San Diego 16
Early research (Phase 1)Study completedNCT00545519
What this trial is testing

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Who this might be right for
Relapsed Or Refractory Multiple Myeloma
Washington University School of Medicine 6
Not applicableStudy completedNCT02710565
What this trial is testing

Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma

Who this might be right for
Lung CancerLymphomaNon-small Cell Lung Cancer+2 more
Mid and South Essex NHS Foundation Trust 22
Early research (Phase 1)UnknownNCT04012892
What this trial is testing

Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Relapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
Chinese PLA General Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01134575
What this trial is testing

CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 90
Not applicableLooking for participantsNCT06819475
What this trial is testing

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

Who this might be right for
Childhood CancerMuscle Weakness
St. Jude Children's Research Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT02756728
What this trial is testing

A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
BioInvent International AB 5
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Early research (Phase 1)UnknownNCT03962465
What this trial is testing

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
University of Virginia 36
Not applicableStudy completedNCT00897767
What this trial is testing

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

Who this might be right for
LeukemiaLymphoma
Eastern Cooperative Oncology Group 1,873
Testing effectiveness (Phase 2)Looking for participantsNCT05243212
What this trial is testing

Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Sheba Medical Center 75
Not applicableUnknownNCT05772000
What this trial is testing

Clinical Significance of Occult Central Nervous System Localization

Who this might be right for
Acute Lymphoblastic Leukemia
University of Rome Tor Vergata 70
Very early researchActive Not RecruitingNCT05302648
What this trial is testing

To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM

Who this might be right for
Multiple Myeloma
Hrain Biotechnology Co., Ltd. 18
Early research (Phase 1)Ended earlyNCT02914938
What this trial is testing

ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Follicular Lymphoma (FL)+4 more
MEI Pharma, Inc. 97
Testing effectiveness (Phase 2)Ended earlyNCT03953326
What this trial is testing

HeartPhone Cancer Survivors Trial 2019

Who this might be right for
Breast CancerLeukemiaLymphoma
Penn State University 2
Not applicableStudy completedNCT04664608
What this trial is testing

Pediatric EEG Monitoring

Who this might be right for
Pediatric ALLEpilepsy
Northwestern University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06852638
What this trial is testing

CD70-targeted immunoPET Imaging of Malignant Cancers

Who this might be right for
Renal CancerRenal Clear Cell CarcinomaLymphoma+4 more
RenJi Hospital 300
Next Page